Top concerns include life expectancy, course of treatment, and pain

About half of patients had sustained reduction in depression and anxiety up to two years after psilocybin and psychotherapy

About half of physicians would consider euthanasia as a good or very good option in a scenario of advanced cancer or Alzheimer disease

One-year incidence of psychosocial therapy initiation was 12.6 percent, while incidence of medication initiation was 2.8 percent

Age-dependent U-shaped trajectories seen for depression and anxiety; symptom levels were significantly higher for survivors

Stronger effects seen for women from some racial/ethnic minority groups and with lower socioeconomic status

Maximal survival benefit seen for smoking cessation treatment within six months of diagnosis

Significant reduction seen in secondary outcome of long-term depression but not in medium-term depression

Increased risk for developing a psychological illness, CVD at one year seen after family member's cancer diagnosis